Search Results - "Horner, Kathleen E."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Risks and benefits of long-term bisphosphonate therapy by Schmidt, Ginelle A, Horner, Kathleen E, McDanel, Deanna L, Ross, Mary B, Moores, Kevin G

    Published in American journal of health-system pharmacy (15-06-2010)
    “…The risks and benefits of long-term bisphosphonate therapy were reviewed. Bisphosphonates are used first line in the treatment of osteoporosis due to their…”
    Get full text
    Journal Article
  2. 2

    Enoxaparin Use and Adverse Events in Outpatients With a Continuous Flow Left Ventricular Assist Device at a Single Institution by Bernard, Allison M., Alvarez, Paulino A., Bream-Rouwenhorst, Heather R., Horner, Kathleen E., Briasoulis, Alexandros, Czerniak, Laura C.

    Published in Journal of pharmacy practice (01-06-2022)
    “…Background: Patients with left ventricular assist devices (LVADs) are anticoagulated with warfarin and may receive enoxaparin bridging for a subtherapeutic…”
    Get full text
    Journal Article
  3. 3

    Evaluation of anticoagulation in patients with antiphospholipid syndrome by Horner, Kathleen E, Phillips, Beth Bryles, Newkirk, Erin, McDanel, Deanna L, Kaboli, Peter

    Published in American journal of health-system pharmacy (15-05-2008)
    “…The quality of anticoagulation therapy in patients with antiphospholipid syndrome (APS) was evaluated. The high risk of unnecessary anticoagulation and recent…”
    Get full text
    Journal Article
  4. 4

    Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care by Schultz, Jordan L., Horner, Kathleen E., McDanel, Deanna L., Miller, Michelle L., Beranek, Randi L., Jacobsen, Ryan B., Sly, Nichole J., Miller, Aaron C., Mascardo, Lisa A.

    Published in Journal of pharmacy practice (01-06-2018)
    “…Background: This study analyzed the impact of a pharmacist-managed diabetes clinic on clinical outcomes compared to usual care received from primary care…”
    Get full text
    Journal Article
  5. 5

    Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population by Lee, James C., Horner, Kathleen E., Krummel, Michelle L., McDanel, Deanna L.

    Published in Journal of pharmacy practice (01-04-2018)
    “…Purpose: To evaluate the efficacy, safety, and indirect financial outcomes of pharmacist face-to-face warfarin management with telephone-based distance…”
    Get full text
    Journal Article
  6. 6

    Effect of a pharmacist managed smoking cessation clinic on quit rates by Philbrick, Ann M., Newkirk, Erin N., B. Farris, Karen, L. McDanel, Deanna, E. Horner, Kathleen

    “…Objective: The purpose of this study was to quantify quit rates, determine factors predicting success, and analyze patients' perceptions at 3 months after…”
    Get full text
    Journal Article
  7. 7

    Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir by Bryant, Ginelle A., McDanel, Deanna L., Horner, Kathleen E., Farris, Karen B., Newkirk, Erin N.

    Published in Pharmacotherapy (01-01-2013)
    “…Study Objectives To evaluate the dose and frequency of insulin detemir for patients with diabetes mellitus undergoing conversion from insulin glargine to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Good Pharmacist: Characteristics, Virtues, and Habits by Horner, Kathleen E

    Published in American journal of health-system pharmacy (01-12-2012)
    “…The Good Pharmacist: Characteristics, Virtues, and Habits By William N. Kelly and Elliott M. Sogol Published by William N. Kelly Consulting Inc., Oldsmar, FL,…”
    Get full text
    Journal Article Book Review